Optimizing Novel Tools to Validate Orphan GPCR Targets

Time: 3:30 pm
day: Day One

Details:

  • Novel ligands and animal models to validate GPR35 and GPR84 as therapeutic targets
  • Use of ‘human specific’ ligands
  • Activation state biomarkers for poorly characterized GPCRs

Speakers: